Extracranial meningioma with extension into a middle ear is very uncommon. A 74-year-old female was admitted to our hospital with right ear bleeding when removing earwax. In this case, magnetic resonance imaging, computed tomography, her past history and operative findings would consider as infiltrative growth from the right sphenoid ridge meningioma to the right middle ear via the right petrous pyramid and bilateral optic nerve. She underwent only partial extirpation with decompression for optic nerve, rather than total extirpation including middle ear and temporal bone, due to wide invasion of the middle cranial fossa and caversinus sinus.
We report herein on a case of reimplantation of a cochlear implant (CI) necessitated by cholesteatoma formation. Although the cholesteatoma had partly invaded the tympanic sinus, the round window niche, and the cochlea, a canal wall down mastoidectomy and expansion of the cochleostomy were useful to remove the cholesteatoma completely. In the replacement with a CI24RECA model we were able to reinsert all electrodes into the cochlea without resistance, and then the results of the neural response telemetry (NRT) were entirely positive. There were no postoperative complications. The postoperative speech perception improved compared with the preoperative findings. About a month after the operation, the patient suffered from otitis media with effusion, but it was cured without puncture and ventilation tube placement in a few weeks. At present there has been no reccurence. In agreement with previous reports, we think that CI reimplantation is an effective and relatively safe procedure.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.